Error 404 - Not Found

Suggestions

YouTube Calendar Photos Documents Reader Sites Groups

Vioxx's History and the Need for Procedural Changes and Better by M Gilhooley - 2007 - Cited by 21 - Related articles mit prompt action when the agency seeks warnings about a drug's become increasingly willing to defer to agency decisions to use in- Stephen Gelson, Director of the Center for New Drugs at the Food and Drug Ad -

Q:\EVEN\ Vioxx \Orders & Reasons\ Vioxx .o&r.Preemption.final5.wpd File Format: PDF/Adobe Acrobat - Quick View by IN RE - Related articles May 9, 2007 appropriate use of a beneficial drug . . . . . State law actions . (A) full reports of investigations which have been made to show .. In the instant cases, Merck argues that the Court must defer to the FDA's recent

JAMA -- Postmarketing Surveillance--Lack of Vigilance, Lack of by PB Fontanarosa - 2004 - Cited by 150 - Related articles JAMA: The Journal Of the American Medical Association . For instance, since adoption of the 1992 Prescription Drug User Fee Act, which augmented the . As the investigations and litigation proceed against the manufacturer of rofecoxib, . FDA officials tried to tone down report on Vioxx . Wall Street Journal.

JAMA -- Postmarketing Surveillance--Lack of Vigilance, Lack of by BM Psaty - 2004 - Cited by 122 - Related articles Nov 22, 2004 For instance, since adoption of the 1992 Prescription Drug User Fee Act, an investigation of 18 FDA expert advisory panels revealed that more than in the unpublished Adenomatous Polyp Prevention on Vioxx (APPROVe) study has . and products for which deferred pediatric studies are needed to

Health Care Renewal: Merck Settles Another Vioxx Case Feb 11, 2010 here about ghost-writing of a Vioxx research publication; immediate action and another to monitor the safety of drugs , a grand-jury investigation of Merck's handling of Vioxx . . Deferred Prosecution Agreements End, So Let the Pa. Sequenom Executive Pleads Guilty, Banned from Lead.

Merck Not Losing Sleep Over Vioxx Disaster And by far, the drug beat out Nike's advertising budget of $78.2 million for an appeal to deny certification of a Vioxx -related class action lawsuit.

Opposition Increases to Prescription Drug Ads - The People's Pharmacy® Jul 4, 2005 Even though the AMA has deferred its decision on consumer drug advertising for. a year, patients should still be cautious.

Drug Advertising Claims: Preemption's New Frontier File Format: PDF/Adobe Acrobat by CM Sharkey - Cited by 2 - Related articles drug advertising , taken up in Part III, hinges on an analysis of the .. Such calls were heightened in the wake of the Vioxx debacle, especially after the 2004 .. enforcement action should the drug manufacturer not address the . regulation in the FDA, [the] Court should defer to the agency's

understands all of the clinical data about Vioxx , dose-related File Format: PDF/Adobe Acrobat - Quick View When the goal of the investigation is to assess the drug's .. It is not entirely clear why Mr. Bolognese was instructed to defer his work on the action on the post-filing PUB's DAP [to not have a post-NDA PUB DAP], it appears to

C&EN Special Issue: Regulatory Trends Jun 19, 2006 Strong action on drug safety and pricing is more likely to come from states as blockbuster medicines, such as the arthritis drug Vioxx , . A number of states are considering proposals to ban direct-to-consumer advertising . . companies are paid to defer the marketing of particular drugs .